echistatin

Subscribe to Selected New Research on echistatin

26 relevant articles (1 outcomes, 7 trials/studies) found for this Bio-Agent

Description: 49 amino acid residues given in first source; from the venom of the viper Echis

Also Known As:

echistatin alpha1; echistatin alpha2; echistatin beta

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins

Peptides: 16375

echistatin: 26

Experts

1.	Squillacioti, C: 2 articles (08/2000 - 07/2000)
2.	Staiano, N: 2 articles (08/2000 - 07/2000)
3.	Belisario, M A: 2 articles (08/2000 - 07/2000)
4.	Della Morte, R: 2 articles (08/2000 - 07/2000)
5.	Talic, Nabeel F: 1 article (02/2006)
6.	Zaki, A Moneim: 1 article (02/2006)
7.	Evans, Carla: 1 article (02/2006)
8.	Tafuri, Simona: 1 article (10/2005)
9.	Belisario, Maria Antonietta: 1 article (10/2005)
10.	Staiano, Norma: 1 article (10/2005)

Related Diseases

1.	Bone Resorption 11/01/1999 - "However, in vivo studies have shown that echistatin, an RGD-containing disintegrin which binds to alpha(v)beta(3), inhibits bone resorption without changing the number of osteoclasts on the bone surface, suggesting inhibition of osteoclast activity. " 09/01/1994 - "Structure-activity studies of the s-echistatin inhibition of bone resorption." 03/01/1993 - "In this study echistatin, a naturally-occurring protein containing an RGD-sequence motif, was shown to completely inhibit osteoclast-mediated bone resorption in vivo. " 03/01/1998 - "These findings provide histological evidence for echistatin binding to osteoclasts and for inhibition of bone resorption in vivo, through reduced osteoclast efficacy, without apparent changes in osteoclast morphology." 03/01/1998 - "Echistatin, an RGD-containing peptide, was shown to inhibit the acute calcemic response to exogenous PTH or PTH-related protein (PTH-rP) in thyroparathyroidectomized rats, suggesting that echistatin inhibits bone resorption. " Order ALL the reference details at left...
2.	Osteoporosis 03/01/1993 - "Echistatin, a potential new drug for osteoporosis." 04/05/1996 - "Because echistatin also inhibits bone resorption, we measured the effects of adding another osteoporosis inhibitor, alendronate, in this system. " 03/01/1993 - "Echistatin or smaller derivative peptides may prove useful in the treatment of disorders characterized by excess bone resorption, such as osteoporosis and metastatic bone disease." Order ALL the reference details at left...
3.	Bone Diseases (Bone Disease) 03/01/1993 - "Echistatin or smaller derivative peptides may prove useful in the treatment of disorders characterized by excess bone resorption, such as osteoporosis and metastatic bone disease." Order ALL the reference details at left...
4.	Melanoma (Melanoma, Malignant) 01/01/1995 - "Echistatin inhibits the adhesion of murine melanoma cells to extracellular matrix components." 08/01/2000 - "The aim of this study was to establish the sequence of events downstream pp125FAK dephosphorylation that could be responsible for echistatin-induced disassembly of actin cytoskeleton and focal adhesions in fibronectin-adherent B16-BL6 melanoma cells. " 08/01/1997 - "B16-BL6 mouse melanoma cells cultured on fibronectin-coated dishes were detached by treatment with echistatin, an RGD-containing disintegrin. " 08/01/1997 - "Echistatin induces decrease of pp125FAK phosphorylation, disassembly of actin cytoskeleton and focal adhesions, and detachment of fibronectin-adherent melanoma cells." 08/01/2000 - "Echistatin inhibits pp125FAK autophosphorylation, paxillin phosphorylation and pp125FAK-paxillin interaction in fibronectin-adherent melanoma cells." Order ALL the reference details at left...
5.	Infection 06/15/2005 - "MV-ERV correctly displayed echistatin on the outer surface of its envelope and produced interesting ring formation phenomena due to cell detachment upon infection of susceptible Vero cells in vitro. " 06/01/2005 - "In this study, three structurally distinct disintegrins (flavoridin, echistatin, kistrin) were used as molecular probes to further characterize the molecular mechanisms underlying Yersinia enterocolitica infection of host cells. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Peptides
2.	Fibronectins (Fibronectin)
3.	Disintegrins
4.	Vitronectin
5.	kistrin
6.	Molecular Probes (Molecular Probe)
7.	Snake Venoms (Snake Venom)
8.	Integrin beta3 (GPIIIa)
9.	Integrins
10.	Venoms

Related Therapies and Procedures

1.	Intravenous Infusions

Best Treatments:
Research Summary Report
on Bone Resorption

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 292 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>